Abstract
Apoptotic cell death in acinar and ductal epithelial cells is thought to play an important role in the development of salivary gland dysfunction in patients with Sjögren's syndrome (SS). We examined the expression of anti-apoptotic molecules in salivary glands from patients with SS. The labial salivary glands from six human T-cell leukemia virus (HTLV)–I–seronegative and eleven HTLV-I–seropositive SS patients were analyzed by immunohistochemistry. In vitro experiments were performed with a human salivary gland cell line (HSG cells). Immunohistologic analyses revealed that Bcl-2 and Bcl-x were preferentially expressed in salivary infiltrating mononuclear cells more than acinar and ductal epithelial cells. In contrast, strong X chromosome-linked inhibitor of apoptosis protein (XIAP) expression was evident in both acinar and ductal epithelial cells. The pattern of expression of these anti-apoptotic molecules was similar in both HTLV-I–seropositive and HTLV-I–seronegative SS patients. Western blot analysis confirmed expression of XIAP in cultured HSG cells. The expression of XIAP in HSG cells was increased by IL-1β, TGF-β1, or IL-10. However, XIAP expression was down-regulated by TNF-α, which induced apoptotic cell death of HSG cells with an increase in caspase-3 activity. These effects of TNF-α in HSG cells were antagonized by IL-1β, TGF-β1, or IL-10. Our results suggest that XIAP is important in regulating apoptotic cell death of acinar and ductal epithelial cells in patients with SS.
Similar content being viewed by others
Introduction
Apoptosis, or programmed cell death, is an essential mechanism for the selective elimination of cells. Deficient or accelerated apoptotic cell death is associated with a variety of disorders, encompassing most cell systems (Thompson, 1995). Sjögren's syndrome (SS) is an organ-specific autoimmune disorder characterized by an infiltration of activated lymphocytes into the salivary glands and destruction of the glandular structure (Klippel and Dieppe, 1998; Koopman, 1997). Recent reports reveal that apoptotic cell death is preferentially found in acinar and ductal epithelial cells more than salivary infiltrating mononuclear cells (MNC) (Kong et al, 1997; Manganelli et al, 1997; Nakamura et al, 1998). This may be a mechanism mediating loss of secretory function of SS. However, the molecular interactions leading to apoptosis of acinar and ductal epithelial cells remain to be clarified.
Caspase-3 is a major effector molecule in inducing apoptotic cell death (Nagata, 1997). The activation of caspase-3 is positively or negatively regulated by at least two kinds of protein families, Bcl-2–related proteins and inhibitor of apoptosis proteins (IAP). Activation of caspase-3 is inhibited by Bcl-2 or Bcl-xL and accelerated by Bax (Chao and Korsmeyer, 1998; Nagata, 1997; Reed, 1997). X chromosome-linked inhibitor of apoptosis protein (XIAP), which is a member of the IAP family of proteins, inhibits caspase-3 activation (Deveraux et al, 1997, 1998).
We previously reported a high prevalence of human T-cell leukemia virus (HTLV)-I Ab in SS patients from certain endemic areas in Japan (Eguchi et al, 1992; Terada et al, 1994). Additionally, a high prevalence of SS in patients with HTLV-I–associated myelopathy (HAM) has also been reported (Nakamura et al, 1997), suggesting that HTLV-I is one of the causative agents of SS. In the present study, we examined the expression of anti-apoptotic molecules expressed in acinar and ductal epithelial cells in salivary glands of SS patients with or without HTLV-I seropositivity. We also investigated the expression and functional properties of XIAP in cultured human salivary gland cell line (HSG cells).
Results
Expression of Bcl-2–Related Proteins and XIAP in Labial Salivary Glands of SS Patients
We initially examined the expression of Bcl-2–related proteins and XIAP in labial salivary glands of SS patients. As we recently described (Nakamura et al, 1999), more than 50% of infiltrating MNC expressed both Bcl-2 and Bcl-x, irrespective of HTLV-I seropositivity. However, Bax was expressed in only a few infiltrating MNC (Fig. 1). The expression of these Bcl-2–related proteins in acinar and ductal epithelial cells was weak compared with the expression in salivary infiltrating MNC (Fig. 1). Expression of Bcl-2, Bcl-x, and Bax was not observed in sections from control subjects (Fig. 1). Although the expression of Bcl-2–related proteins was not obvious in either acinar or ductal epithelial cells, strong XIAP expression was determined in both cell types from SS patients, irrespective of HTLV-I seropositivity (Fig. 2). Expression of XIAP was not observed in sections from control subjects (Fig. 2). In contrast to acinar and ductal epithelial cells, XIAP expression was not clear in salivary infiltrating MNC (Fig. 2).
Modulation of XIAP Expression in HSG Cells by Cytokines
Our immunohistochemistry results suggested that XIAP was an important molecule regulating apoptosis in acinar and ductal epithelial cells. Various cytokines have been detected in situ in salivary glands of SS patients (Klippel and Dieppe, 1998; Koopman, 1997). Therefore, we investigated whether cytokines could modulate the expression of XIAP, which regulates an apoptotic process, in cultured HSG cells. In concordance with previous reports (Klippel and Dieppe, 1998; Koopman, 1997), strong expression of IL-1β, TNF-α, transforming growth factor β1 (TGF-β1), and IL-10 was detected in salivary glands from SS patients (Fig. 3). TNF-α expression was mainly confined to infiltrating MNC. IL-1β, TGF-β1, and IL-10 were expressed in both infiltrating MNC and acinar/ductal epithelial cells (Fig. 3). Culture of HSG cells with TNF-α decreased XIAP expression (Fig. 4). A clear induction of apoptosis was found in HSG cells treated with TNF-α; along with an increase in caspase-3 activity, XIAP expression was markedly decreased (Figs. 4, 5 and 6). The addition of Ac-DEVD (Asp-Glu-Val-Asp)-aldehyde almost completely suppressed the appearance of hypodiploid DNA+ HSG cells induced by TNF-α (data not shown). This suggests that caspase-3 is a major effector molecule in the TNF-α–induced apoptosis of HSG cells. In contrast, XIAP expression in HSG cells was increased by IL-1β, TGF-β1, or IL-10 (Fig. 4). The decrease of XIAP expression by TNF-α in HSG cells was antagonized by the presence of IL-1β, TGF-β1, or IL-10, almost to the levels found in unstimulated HSG cells (Fig. 7). Induction of apoptotic cell death and caspase-3 activity in HSG cells by TNF-α was suppressed, although not completely inhibited, by IL-1β, TGF-β1, or IL-10 (Figs. 5 and 6). The in situ expression of IL-10 receptor (IL-10R) was confirmed in acinar and ductal epithelial cells of SS patients and in cultured HSG cells (Fig. 8).
Discussion
Recent immunohistologic examinations revealed the presence of apoptotic cell death in salivary glands from patients with SS, in acinar and ductal epithelial cells more than in salivary infiltrating MNC (Kong et al, 1997; Manganelli et al, 1997; Nakamura et al, 1998). Therefore, an apoptotic cell death of acinar and ductal epithelial cells could be a major mechanism perpetuating the destruction of the salivary gland.
Here, immunohistologic analysis suggested that XIAP is an important anti-apoptotic molecule expressed in acinar and ductal epithelial cells. The expression of Bcl-2 and Bcl-x was quite weak in acinar and ductal epithelial cells compared with XIAP expression. Therefore, we examined the expression and function of XIAP in cultured HSG cells. XIAP is a member of IAP family proteins, which inhibit caspase-3 activation (Deveraux et al, 1997, 1998). Cytokines or adhesion molecules could be extrinsic factors involved in the modulation of apoptosis. Various cytokines that might modulate the expression of XIAP in acinar and ductal epithelial cells are produced in the salivary glands of SS. We examined the modulation of XIAP expression in cultured HSG cells. HSG cells did not undergo spontaneous apoptosis in culture, and clearly expressed XIAP. Culture of HSG cells with IL-1β, TGF-β1, or IL-10 increased the expression of XIAP. In contrast, the expression of XIAP in HSG cells was significantly reduced by TNF-α, and apoptotic cell death with an increase in caspase-3 activity was found in the TNF-α–treated HSG cells. This indicates a functional significance of XIAP in regulating the apoptotic cell death of HSG cells. When HSG cells were cultured with TNF-α in the presence of IL-1β, TGF-β1, or IL-10, the TNF-α–induced apoptosis of HSG cells with increase of caspase-3 activity was inhibited by IL-1β, TGF-β1, or IL-10. With IL-1β, TGF-β1, or IL-10, the decrease of XIAP expression in TNF-α–treated HSG cells was almost recovered to levels found in unstimulated HSG cells. These results suggest that cytokines produced in the salivary glands in SS regulate apoptosis of acinar and ductal epithelial cells by modulating XIAP expression. However, anti-apoptotic molecules other than XIAP, such as cIAP1, cIAP2, or survivin (Deveraux et al 1998; Tamm et al, 1998), could be involved in TNF-α–induced HSG cell apoptosis because approximately half of the caspase-3 activity-inducing apoptosis of TNF-α–treated HSG cells still remained after the addition of IL-1β, TGF-β1, or IL-10.
We have demonstrated that apoptosis of acinar and ductal epithelial cells is modulated by XIAP, and that XIAP expression could be positively or negatively regulated by cytokines expressed in salivary glands of SS patients. We also found that XIAP expression was independent of HTLV-I–seropositivity, indicating that common molecular mechanisms may regulate apoptosis in the salivary glands, independent of the pathologic organism. Our findings may also provide new insight into the development of cell-type–specific immunotherapy for SS by modulating the expression of apoptosis-related molecules.
Materials and Methods
Patients
All patients were female and fulfilled the criteria for diagnosis of SS as defined by the European Community (Vitali et al, 1993). Six HTLV-I–seronegative (48.2 ± 26.5 years old, range: 19 to 86 years old) and eleven HTLV-I–seropositive SS patients were entered in the study. The latter group comprised five patients with HAM (59.0 ± 11.7 years old, range: 40 to 72) and six patients without HAM (54.0 ± 15.1 years old, range: 40 to 72). The five HAM patients were diagnosed according to the criteria proposed by Osame et al (1987). Control subjects had sicca symptoms, but were not diagnosed as SS. Patients with SS secondary to other autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, or progressive systemic sclerosis, were not included. Informed consent was obtained from all participating subjects and the study was conducted in accordance with the human experimental guidelines of our institution.
Biopsy of Labial Salivary Glands
Biopsies of minor labial salivary glands were obtained from the mucosa of the lower lip, 0.5 to 1.0 cm lateral to midline, under local anesthesia. Tissues were fixed in 4% paraformaldehyde in PBS (pH 7.4) immediately after biopsy, and were successively immersed in 10%, 15%, and 20% sucrose before being frozen in liquid nitrogen and stored at −80° C until use.
Monoclonal and Polyclonal Abs for Immunohistochemistry
A polyclonal antibody that recognizes the N-terminal portion of Bax and a monoclonal antibody to TGF-β1 were purchased from Santa Cruz Biotechnology (Santa Cruz, California). A monoclonal antibody to Bcl-2 was purchased from Dako (Glostrup, Denmark). A polyclonal antibody to Bcl-x, which recognizes both the Bcl-xS and the Bcl-xL isoforms, was purchased from Transduction Laboratories (Lexington, Kentucky). A monoclonal antibody to XIAP was purchased from MBL (Nagoya, Japan). IL-10 monoclonal and IL-10R polyclonal antibodies were purchased from R&D Systems (Minneapolis, Minnesota). Monoclonal antibodies to TNF-α and IL-1β were purchased from Genzyme (Cambridge, Massachusetts).
Immunohistochemical Examination of Salivary Glands
Four-micron thick tissue sections of labial salivary glands were cut and mounted on aminopropyltriethoxysilane-coated glass slides. The streptavidin-biotin method (Histofine Staining Kit; Nichirei Company, Tokyo, Japan) was used for immunohistochemical detection, as described previously (Nakamura et al, 1997). Briefly, endogenous peroxidase was inactivated by immersing the section in a 3% hydrogen peroxide solution. Sections were incubated with 10% goat or rabbit serum, then incubated with primary antibody in a humidified chamber for 60 minutes at room temperature (except the IL-10R antibody, which was incubated overnight). The sections were next incubated with the appropriate biotinylated anti-rabbit or anti-mouse IgG for 12 minutes, washed, and incubated with peroxidase-conjugated streptavidin. Color was developed using 3.3′-diaminobenzidine and hydrogen peroxide. Negative control sections were incubated with either normal mouse IgG or normal rabbit serum.
Effect of Cytokines on Apoptotic Cell Death in Cultured HSG Cells
The HSG cell line (Sato et al, 1985), established from a human salivary gland, was a kind gift from Dr. Yoshio Hayashi (Tokushima University School of Dentistry, Tokushima, Japan). HSG cells (1 × 105 cells per well in 6-well tissue culture plates, Costar 3516; Costar, Cambridge, Massachusetts) were cultured in E-MEM containing 2% BSA in the presence or absence of TNF-α (200 IU/ml; Kirin, Tokyo, Japan), IL-1β (20 IU/ml; Otsuka Pharmaceutical Company, Tokushima, Japan), IL-10 (20 ng/ml, Genzyme), or TGF-β1 (5 ng/ml, Kirin) for 72 hours. After incubation, apoptotic cell death, activation of caspase-3, and the expression of XIAP in HSG cells were examined. Apoptotic cell death was quantified by the percentage of cells with hypodiploid DNA as previously described (Kawakami et al, 1999). Briefly, treated HSG cells were fixed with 70% ethanol, treated with RNase (100 μg/ml, Sigma Chemical Company, St. Louis, Missouri), and stained with propidium iodide (100 μg/ml, Sigma) for 30 minutes, on ice. The stained cells were analyzed by a flow cytometer (Epics XL, Beckman Coulter, Hialeah, Florida) to detect the presence of the cells with hypodiploid DNA.
We examined intracellular caspase-3 activity in HSG cells by flow cytometry using the PhiPhiLux G1D2 Kit (MBL). Briefly, treated HSG cells were centrifuged to remove the culture medium. DEVD substrate containing rhodamine was added to the cell pellet and incubated in a 5% CO2 incubator at 37° C for 60 minutes. After incubation, samples were analyzed by flow cytometer (Epics XL) to determine the percentage of intracellular active caspase-3+ cells. To examine the functional significance of caspase-3 in apoptotic process of HSG cells, 300 μm of Ac-DEVD-aldehyde (DEVD-CHO, Peptide institute, Osaka, Japan) was added to HSG cells 3 hours before the addition of cytokines. The percentage of cells with hypodiploid DNA was determined as described above.
Western Blot Analysis for the Expression of XIAP and IL-10R in HSG Cells
HSG cells were collected after incubation in the presence or absence of TNF-α (200 IU/ml, Kirin), IL-1β (20 IU/ml, Otsuka Pharmaceutical Company), IL-10 (20 ng/ml, Genzyme), or TGF-β1 (5 ng/ml, Kirin) for 72 hours in E-MEM supplemented with 2% BSA as described above, and lysed with lysis buffer (1% NP-40; 50 mm Tris, pH 7.5; 100 mm NaCl; 5 mm EDTA; 1 mm polymethylsulfonylfluoride) for 20 minutes at 4° C. Insoluble materials were removed by centrifugation at 14,000 rpm for 30 minutes at 4° C. Supernatants were collected, and protein concentrations determined using the Bio-Rad protein assay kit (Melville, New York). An identical amount of protein (20 μg) for each lysate was subjected to 10% SDS-PAGE, before being transferred to nitrocellulose filters. Filters were blocked for 1.5 hours using 5% nonfat dried milk in TBS (50 mm Tris, 0.15 M NaCl, pH 7.5) containing 0.1% Tween 20, washed with TBS, and incubated at room temperature for 2 hours in a 1:1000 dilution of XIAP mAb or IL-10R Ab. Filters were washed with TBS and incubated with a 1:1000 dilution of secondary antibody coupled to horseradish peroxidase. The enhanced chemiluminescence (ECL) system (Amersham, Arlington Heights, Illinois) was used for detection. A monoclonal antibody to β-actin (Sigma) was used as an internal control protein.
References
Chao DT and Korsmeyer SJ (1998). BCL-2 family: Regulators of cell death. Annu Rev Immunol 16: 395–419.
Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, and Reed JC (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17: 2215–2223.
Deveraux QL, Takahashi R, Salvesen GS, and Reed JC (1997). X-linked IAP is a direct inhibitor of cell death proteases. Nature 388: 300–303.
Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y, Fukuda T, Sawada T, and Nagataki S (1992). Primary Sjögren's syndrome with antibodies to HTLV-I: Clinical and laboratory features. Ann Rheum Dis 51: 769–776.
Kawakami A, Nakashima T, Sakai H, Urayama S, Yamasaki S, Hida A, Tsuboi M, Nakamura H, Ida H, Migita K, Kawabe Y, and Eguchi K (1999). Inhibition of caspase cascade by HTLV-I Tax through induction of NF-κB nuclear translocation. Blood 94: 3847–3854.
Klippel JH and Dieppe PA (1998). Rheumatology, 2nd ed. London: Mosby, Ch 7.32.
Kong L, Ogawa N, Nakabayashi T, Liu GT, D'Souza E, McGuff HS, Guerrero D, Talal N, and Dang H (1997). Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40: 87–97.
Koopman WJ (1997). Arthritis and allied conditions: A textbook of rheumatology, 13th ed. Williams & Wilkins, Baltimore: 1561–1580.
Manganelli P, Quaini F, Andreoli AM, Lagrasta C, Pilato FP, Zuccarelli A, Monteverdi R, D'Aversa C, and Olivetti G (1997). Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome. J Rheumatol 24: 1552–1557.
Nagata S (1997). Apoptosis by death factor. Cell 88: 355–365.
Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, Matsuoka N, Migita K, Kawabe Y, and Nagataki S (1997). High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56: 167–172.
Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T, and Eguchi K (1999). Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome. Lab Invest 79: 261–269.
Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y, Nakamura T, Shirabe S, and Eguchi K (1998). Apoptosis in labial salivary glands from Sjögren's syndrome patients: Comparison with the HTLV-I–seronegative and –seropositive Sjögren's syndrome patients. Clin Exp Immunol 114: 106–112.
Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, and Igata A (1987). Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T cell leukemia-like cells. Ann Neurol 21: 117–122.
Reed JC (1997). Cytochrome c: Can't live with it—can't live without it. Cell 91: 559–562.
Sato M, Hayashi Y, Yanagawa T, Yoshida H, Yura Y, Azuma M, and Ueno A (1985). Intermediate-sized filaments and specific markers in a human salivary gland adenocarcinoma cell line and its nude mouse tumors. Cancer Res 45: 3878–3890.
Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, and Reed JC (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315–5320.
Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, and Miyamoto T (1994). Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 344: 1116–1119.
Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462.
Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiødt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, and Youinou P (1993). Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36: 340–347.
Acknowledgements
This work was supported in part by a Grant-in-Aid (05670426) from the Ministry of Education, Science, Sport and Culture, Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakamura, H., Kawakami, A., Yamasaki, S. et al. Expression and Function of X Chromosome-Linked Inhibitor of Apoptosis Protein in Sjögren's Syndrome. Lab Invest 80, 1421–1427 (2000). https://doi.org/10.1038/labinvest.3780149
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/labinvest.3780149